Andrea Arruda

3.7k total citations
39 papers, 566 citations indexed

About

Andrea Arruda is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Andrea Arruda has authored 39 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 16 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Andrea Arruda's work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Andrea Arruda is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Andrea Arruda collaborates with scholars based in Canada, United States and Germany. Andrea Arruda's co-authors include Mark D. Minden, Ching Wen Tseng, George Y. Liu, Wafa Tawackoli, V. Krishnan Ramanujan, Pierre Kyme, Hyeonjeong Kang, Jong Bok Lee, Chaojie Liu and Aaron D. Schimmer and has published in prestigious journals such as Blood, Bioinformatics and The Journal of Immunology.

In The Last Decade

Andrea Arruda

33 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Arruda Canada 10 255 188 163 159 69 39 566
Matthew P. Mulè United States 10 259 1.0× 196 1.0× 105 0.6× 105 0.7× 24 0.3× 14 521
Jingmei Hsu United States 14 90 0.4× 325 1.7× 262 1.6× 200 1.3× 118 1.7× 50 696
Manuel Schmidt Germany 14 603 2.4× 273 1.5× 353 2.2× 214 1.3× 145 2.1× 50 1.0k
Jörg Schüttrumpf Germany 14 135 0.5× 205 1.1× 99 0.6× 166 1.0× 86 1.2× 39 588
Gisela Cáceres United States 15 350 1.4× 360 1.9× 118 0.7× 195 1.2× 105 1.5× 27 787
Louis van de Locht Netherlands 7 117 0.5× 388 2.1× 160 1.0× 191 1.2× 40 0.6× 9 641
Daniela Werth Germany 9 338 1.3× 246 1.3× 221 1.4× 63 0.4× 37 0.5× 12 659
Mohey Eldin El Shikh United States 15 484 1.9× 174 0.9× 117 0.7× 49 0.3× 23 0.3× 24 767
Sören Reinke United Kingdom 7 248 1.0× 188 1.0× 101 0.6× 54 0.3× 18 0.3× 11 443
Sahar Kassem France 11 390 1.5× 271 1.4× 318 2.0× 157 1.0× 18 0.3× 16 723

Countries citing papers authored by Andrea Arruda

Since Specialization
Citations

This map shows the geographic impact of Andrea Arruda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Arruda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Arruda more than expected).

Fields of papers citing papers by Andrea Arruda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Arruda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Arruda. The network helps show where Andrea Arruda may publish in the future.

Co-authorship network of co-authors of Andrea Arruda

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Arruda. A scholar is included among the top collaborators of Andrea Arruda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Arruda. Andrea Arruda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Andy G.X., Ilaria Iacobucci, Amanda Mitchell, et al.. (2025). Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation. Blood Cancer Discovery. 6(4). 307–324. 8 indexed citations
2.
Culp‐Hill, Rachel, Andrea Arruda, Tracy Murphy, et al.. (2025). Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia. Blood. 146(21). 2589–2596.
3.
Cathelin, Séverine, David Dai, Éric Grignano, et al.. (2025). Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors. PubMed. 3(1). 100182–100182.
4.
Zeng, Andy G.X., Ilaria Iacobucci, Amanda Mitchell, et al.. (2024). 2020 – PRECISE SINGLE-CELL TRANSCRIPTOMIC MAPPING OF NORMAL AND LEUKEMIC CELL STATES REVEALS UNCONVENTIONAL LINEAGE PRIMING IN ACUTE MYELOID LEUKEMIA. Experimental Hematology. 137. 104577–104577. 1 indexed citations
5.
Cathelin, Séverine, David Dai, Éric Grignano, et al.. (2024). Single-Cell Proteogenomic Analysis of Clonal Evolution in Patient-Derived Xenograft Models of AML Treated with IDH Inhibitors. Blood. 144(Supplement 1). 4995–4995.
6.
Davidson, Marta, James A. Kennedy, José‐Mario Capo‐Chichi, et al.. (2024). Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood Advances. 8(5). 1281–1294. 5 indexed citations
7.
Morgenstern, Yael, Jong Bok Lee, William D. Gwynne, et al.. (2024). Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing. Haematologica. 110(4). 893–903. 2 indexed citations
8.
Castro, Fabíola Attié de, Parinaz Mehdipour, Ankur Chakravarthy, et al.. (2023). Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia. British Journal of Haematology. 204(1). 206–220. 2 indexed citations
9.
Medeiros, Jessie J.F., José‐Mario Capo‐Chichi, Liran I. Shlush, et al.. (2022). SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data. Bioinformatics. 38(8). 2088–2095. 4 indexed citations
10.
Boutzen, Héléna, Seyed Ali Madani Tonekaboni, Michelle Chan‐Seng‐Yue, et al.. (2022). A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome. Leukemia. 36(11). 2690–2704. 7 indexed citations
11.
Zhao, Zhen, et al.. (2022). Cell-free DNA topology depends on its subcellular and cellular origins in cancer. JCI Insight. 7(20). 14 indexed citations
12.
Berman, Jacob M., Rachel Culp‐Hill, Julie A. Reisz, et al.. (2021). Sirtuin 3 Inhibition Targets AML Stem Cells through Perturbation of Fatty Acid Oxidation. Blood. 138(Supplement 1). 2240–2240. 2 indexed citations
13.
Lee, Jong Bok, Mark D. Minden, Weihsu C. Chen, et al.. (2017). Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms. Clinical Cancer Research. 24(2). 370–382. 80 indexed citations
14.
Menghrajani, Kamal, Franck Rapaport, Caroline McNamara, et al.. (2017). SETBP1 and NRAS Mutations Are Frequent Events in Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML) Lacking JAK-STAT Activating Mutations. Blood. 130. 203–203. 1 indexed citations
15.
Xie, Liji, Mark Biondo, Samantha J. Busfield, et al.. (2017). CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission. Blood Cancer Journal. 7(6). e567–e567. 36 indexed citations
16.
Huang, Ju, Dwayne L. Barber, Andrea Arruda, et al.. (2016). Preclinical validation: LV/IL-12 transduction of patient leukemia cells for immunotherapy of AML. Molecular Therapy — Methods & Clinical Development. 3. 16074–16074. 17 indexed citations
17.
Dzneladze, Irakli, John F. Woolley, Meong Hi Son, et al.. (2015). INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia. Leukemia. 29(7). 1485–1495. 43 indexed citations
18.
Tseng, Ching Wen, Pierre Kyme, Andrea Arruda, et al.. (2012). Innate Immune Dysfunctions in Aged Mice Facilitate the Systemic Dissemination of Methicillin-Resistant S. aureus. PLoS ONE. 7(7). e41454–e41454. 86 indexed citations
19.
Tseng, Ching Wen, et al.. (2011). Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA). Journal of Visualized Experiments. 20 indexed citations
20.
Wolf, Andrea J., Andrea Arruda, Christopher N. Reyes, et al.. (2011). Phagosomal Degradation Increases TLR Access to Bacterial Ligands and Enhances Macrophage Sensitivity to Bacteria. The Journal of Immunology. 187(11). 6002–6010. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew P. Mulè Breakdown of academic impact, for papers by Jingmei Hsu Breakdown of academic impact, for papers by Manuel Schmidt Breakdown of academic impact, for papers by Jörg Schüttrumpf Breakdown of academic impact, for papers by Gisela Cáceres Breakdown of academic impact, for papers by Louis van de Locht Breakdown of academic impact, for papers by Daniela Werth Breakdown of academic impact, for papers by Mohey Eldin El Shikh Breakdown of academic impact, for papers by Sören Reinke Breakdown of academic impact, for papers by Sahar Kassem
Rankless by CCL
2026